Ainos Inc. Director of Corporate Development Jack Lu on Veldona Drug Development episode artwork

EPISODE · Oct 23, 2024 · 22 MIN

Ainos Inc. Director of Corporate Development Jack Lu on Veldona Drug Development

from WTR Small-Cap Spotlight

Send us Fan MailJack Lu, Director of Corporate Development, of Ainos joins us on this week’s WTR Small-Cap Spotlight to discuss the therapeutic platform and Veldona clinical development. He reviews the effects of Veldona on the immune system and benefit seen in prior clinical trials. Jack focuses on the recently announced studies being conducted in Taiwan for the three priority indications of oral warts in HIV+ patients, Sjogren’s syndrome, and cat FCGS in animal health. We get a sense of timelines for potential data catalysts and outcome goals.

Episode metadata supplied by the publisher feed · Published Oct 23, 2024

Embed this episode

NOW PLAYING

Ainos Inc. Director of Corporate Development Jack Lu on Veldona Drug Development

0:00 22:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of WTR Small-Cap Spotlight?

This episode is 22 minutes long.

When was this WTR Small-Cap Spotlight episode published?

This episode was published on October 23, 2024.

Can I download this WTR Small-Cap Spotlight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!